Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study
暂无分享,去创建一个
[1] N. Morsi,et al. RETRACTED ARTICLE: Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: In-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation. , 2019, Drug development and industrial pharmacy.
[2] D. A. El-Setouhy,et al. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size , 2019, AAPS PharmSciTech.
[3] M. Razeghinejad,et al. Managing normal tension glaucoma by lowering the intraocular pressure. , 2019, Survey of ophthalmology.
[4] Abdelhalim I. Elassasy,et al. Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies , 2018, International journal of pharmaceutics.
[5] Young Kook Kim,et al. Metal-organic frameworks, NH2-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine. , 2018, Acta biomaterialia.
[6] A. Elshafeey,et al. A novel concept of overcoming the skin barrier using augmented liquid nanocrystals: Box-Behnken optimization, ex vivo and in vivo evaluation. , 2018, Colloids and surfaces. B, Biointerfaces.
[7] Rania M. Hathout,et al. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in‐vivo efficacy and safe histological profile , 2018, International journal of pharmaceutics.
[8] H. Kaji,et al. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. , 2018, Materials science & engineering. C, Materials for biological applications.
[9] M. Kassem,et al. Dry Gel Containing Optimized Felodipine-Loaded Transferosomes: a Promising Transdermal Delivery System to Enhance Drug Bioavailability , 2018, AAPS PharmSciTech.
[10] Ghada M. Elsayed,et al. Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex‐vivo permeation study‐Box‐Cox transformation practical example , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] Hsieh-Chih Tsai,et al. Formulation and evaluation of epinephrine-loaded poly(acrylic acid-co-N-isopropylacrylamide) gel for sustained ophthalmic drug delivery , 2018 .
[12] A. Elshafeey,et al. Ultrahigh verapamil-loaded controlled release polymeric beads using superamphiphobic substrate: D-optimal statistical design, in vitro and in vivo performance , 2018, Drug delivery.
[13] Doaa Hegazy,et al. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits , 2018, Drug delivery.
[14] Ahmed Abdelbary,et al. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation , 2018, Drug delivery.
[15] D. A. El-Setouhy,et al. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies , 2017, Drug Delivery.
[16] I. Elsayed,et al. Tailored nanostructured platforms for boosting transcorneal permeation: Box–Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization , 2017, International journal of nanomedicine.
[17] G. K. Jani,et al. Development of RP-HPLC Method for Simultaneous Determination of Brimonidine Tartrate and Brinzolamide by QbD Approach and Its Validation , 2017 .
[18] Ying Huang,et al. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation , 2017, AAPS PharmSciTech.
[19] Xinghuai Sun,et al. Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma. , 2017, ACS applied materials & interfaces.
[20] A. O. Kamel,et al. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies , 2017, Drug delivery.
[21] G. Abdelbary,et al. Engineering of a novel optimized platform for sublingual delivery with novel characterization tools: in vitro evaluation and in vivo pharmacokinetics study in human , 2017, Drug delivery.
[22] Xin He,et al. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation , 2016, Nanoscale Research Letters.
[23] Munish Ahuja,et al. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide , 2016, Drug delivery.
[24] Vivek S. Dave,et al. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel , 2015, AAPS PharmSciTech.
[25] M. I. Mohamed,et al. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. , 2015, International journal of pharmaceutics.
[26] Christopher G Owen,et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis , 2015, British Journal of Ophthalmology.
[27] M. I. Tadros,et al. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. , 2015, International journal of pharmaceutics.
[28] K. Pathak,et al. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study , 2014, Drug development and industrial pharmacy.
[29] P. Ma,et al. Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems , 2014, BioMed research international.
[30] G. Abdelbary,et al. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[31] N. K. Jain,et al. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits. , 2014, International journal of pharmaceutics.
[32] Baoyan Wang,et al. Ophthalmic Delivery of Brinzolamide by Liquid Crystalline Nanoparticles: In Vitro and In Vivo Evaluation , 2013, AAPS PharmSciTech.
[33] Poonam Sharma,et al. Effect of nano-filler on electrical properties of PVA-PEO blend polymer electrolyte , 2013 .
[34] S. Li,et al. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies , 2013, International journal of nanomedicine.
[35] Heinz Holling,et al. An Introduction to Optimal Design Some Basic Issues Using Examples From Dyscalculia Research , 2013 .
[36] R. Ilavarasan,et al. FORMULATION AND EVALUATION OF NIOSOMAL IN SITU GEL OCULAR DELIVERY SYSTEM OF BRIMONIDINE TARTRATE , 2012 .
[37] A. Mahmoud,et al. Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation , 2011, AAPS PharmSciTech.
[38] Prakash Bhagav,et al. Brimonidine Tartrate–Eudragit Long-Acting Nanoparticles: Formulation, Optimization, In Vitro and In Vivo Evaluation , 2011, AAPS PharmSciTech.
[39] S. Maiti,et al. Nanovesicular Formulation of Brimonidine Tartrate for the Management of Glaucoma: In Vitro and In Vivo Evaluation , 2011, AAPS PharmSciTech.
[40] R. Charyulu,et al. Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System , 2010, Journal of young pharmacists : JYP.
[41] L. Gan,et al. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability , 2010, Acta Pharmacologica Sinica.
[42] F. Tiberg,et al. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. , 2010, International journal of pharmaceutics.
[43] Qiang Zhang,et al. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system , 2010, Journal of microencapsulation.
[44] D. Shastri,et al. Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery , 2010, Journal of young pharmacists : JYP.
[45] T. Rades,et al. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. , 2009, Journal of pharmaceutical sciences.
[46] J. Czernuszka,et al. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres. , 2009, Journal of pharmaceutical sciences.
[47] A. Mahmoud,et al. Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride , 2009, AAPS PharmSciTech.
[48] L. McLoon,et al. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. , 2009, Archives of ophthalmology.
[49] R. Cortesi,et al. Lipid-based supramolecular systems for topical application: A preformulatory study , 2003, AAPS PharmSci.
[50] R. Müller,et al. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[51] P. Ashok,et al. Design of ocular inserts of brimonidine tartrate by response surface methodology , 2007 .
[52] H. Edelhauser,et al. Ocular drug delivery , 2006, Expert opinion on drug delivery.
[53] L. Cimino,et al. Effect of Brimonidine on Intraocular Pressure in Normal Tension Glaucoma: A Short Term Clinical Trial , 2003, European journal of ophthalmology.
[54] Paul Tavan,et al. A fast multipole method combined with a reaction field for long-range electrostatics in molecular dynamics simulations: The effects of truncation on the properties of water , 2003 .
[55] M. Nakano,et al. Small-Angle X-ray Scattering and 13C NMR Investigation on the Internal Structure of “Cubosomes” , 2001 .
[56] D. Quintanar-Guerrero,et al. Monoolein: A Review of the Pharmaceutical Applications , 2000, Drug development and industrial pharmacy.
[57] J. W. Moore,et al. Mathematical comparison of dissolution profiles , 1996 .
[58] Yongcheol Shin,et al. An Autoregressive Distributed Lag Modelling Approach to Cointegration Analysis , 1995 .
[59] Edward J. Haug,et al. Introduction to optimal design , 1989 .
[60] John H. Draize,et al. METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .